Obesity Research · Vol. 2, No. 1 · 2015 · pp. e5–e7 · e-ISSN 2377-8385

New Insight on Adipose Tissue Function in Advanced Renal Failure

Mohammad Javad Hosseinzadeh-Attar, Elham Alipoor

DOI: https://doi.org/10.17140/oroj-2-e002 · Published 2015-04-17 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2015 The Author(s)

Also available as PDF (figures and tables appear in the PDF).

Abstract

Adipose tissue has been considered simply as an exclusive fat storage organ for a long period. Later in the mid-1990s and after identification of leptin, a revolution occurred in understanding of white adipose tissue function. In fact, adipose tissue has been recognized as a dynamic endocrine organ, which could affect whole body homeostasis.1 Thereafter, more than 50 secretory peptides, which are called “adipokines” or “adipocytokines”, with diverse metabolic functions have been identified2 and the biological role of adipose tissue became more sophisticated and interesting. The adipokines may act through an autocrine, paracrine and endocrine manner. They are supposed to be involved in a wide range of physiologic to pathologic processes including dietary intake and appetite regulation, energy expenditure, insulin resistance, lipid metabolism, immunity, inflammation and acute-phase responses, vascular homeostasis, endothelial function, angiogenesis and so on.2,3Leptin, adiponectin, ghrelin, resistin, visfatin, vaspin, omentin, TNF-α, and IL-6 are among the most studied adipokines in health and disease. However, studies regarding the extensive biological and metabolic functions of adipokines are still ongoing.

Keywords: sophisticated; adipocytokines

Acknowledgments

We should thank Tehran University of Medical Sciences for their full support.

References

  1. ZhangYProencaRMaffeiMBaroneMLeopoldLFriedmanJM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432. doi: 10.1038/372425a010.1038/372425a0 https://doi.org/10.1038/372425a0
  2. TrayhurnPWoodIS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92: 347-355. doi: 10.1079/BJN2004121310.1079/bjn20041213 https://doi.org/10.1079/bjn20041213
  3. LagoFDieguezCGomez-ReinoJGualilloO. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007; 18: 313-325. doi: 10.1016/j.cytogfr.2007.04.00710.1016/j.cytogfr.2007.04.007 https://doi.org/10.1016/j.cytogfr.2007.04.007
  4. RusterCWolfG. Adipokines promote chronic kidney disease. Nephrol Dial Transplant. 2013; 28(Suppl 4): iv8-14. doi: 10.1093/ ndt/gft191
  5. OhashiKShibataRMuroharaTOuchiN. Role of anti-inflammatory adipokines in obesity-related diseases. Trends in endocrinology and metabolism: TEM. 2014; 25: 348-355. doi: 10.1016/j.tem.2014.03.00910.1016/j.tem.2014.03.009 https://doi.org/10.1016/j.tem.2014.03.009
  6. BriffaJFMcAinchAJPoronnikPHryciwDH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013; 305: F1629-F1636. doi: 10.1152/ajprenal.00263.201310.1152/ajprenal.00263.2013 https://doi.org/10.1152/ajprenal.00263.2013
  7. BriffaJFGrinfeldEMcAinchAJPoronnikPHryciwDH. Short term exposure to elevated levels of leptin reduces proximal tubule cell metabolic activity. Mol Cell Endocrinol. 2014; 382: 38-45. doi: 10.1016/j.mce.2013.09.00110.1016/j.mce.2013.09.001 https://doi.org/10.1016/j.mce.2013.09.001
  8. IglesiasPDiezJJ. Adipose tissue in renal disease: clinical 2010; 25: 2066-2077. doi: 10.1093/ndt/gfq24610.1093/ndt/gfq246 https://doi.org/10.1093/ndt/gfq246
  9. AxelssonJStenvinkelP. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008; 17: 25-31
  10. JiaTCarreroJJLindholmBStenvinkelP. The complex 2150-2156. doi: 10.1016/j.biochi.2012.02.02410.1016/j.biochi.2012.02.024 https://doi.org/10.1016/j.biochi.2012.02.024
  11. MenonVLiLWangX. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17: 2599-2606. doi: 10.1681/ASN.200604033110.1681/asn.2006040331 https://doi.org/10.1681/asn.2006040331
  12. JorsalATarnowLFrystykJ. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008; 74: 649-654. doi: 10.1038/ki.2008.20110.1038/ki.2008.201 https://doi.org/10.1038/ki.2008.201
  13. RussellSTTisdaleMJ. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology. 2010; 151: 948-957. doi: 10.1210/en.2009-082710.1210/en.2009-0827 https://doi.org/10.1210/en.2009-0827
  14. MracekTDingQTzanavariT. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf). 2010; 72: 334-341. doi: 10.1111/j.1365-2265.2009.03658.x10.1111/j.1365-2265.2009.03658.x https://doi.org/10.1111/j.1365-2265.2009.03658.x
  15. Ceperuelo-MallafreVNafSEscoteX. Circulating obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab. 2009; 94: 5062-5069. doi: 10.1210/jc.2009-076410.1210/jc.2009-0764 https://doi.org/10.1210/jc.2009-0764
  16. EckardtKSchoberAPlatzbeckerB. The adipokine zinc-alpha2-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem. 2011; 117: 88-93. doi: 10.3109/13813455.2011.56095010.3109/13813455.2011.560950 https://doi.org/10.3109/13813455.2011.560950
  17. BingCRussellSTBeckettEE. Expression of uncoupling proteins-1, -2 and-3 mRNA is induced by an adenocarcinomaderived lipid-mobilizing factor. Br J Cancer. 2002; 86: 612-618
  18. GaoDTrayhurnPBingC. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol. 2010; 325: 135-142. doi: 10.1016/j.mce.2010.05.02010.1016/j.mce.2010.05.020 https://doi.org/10.1016/j.mce.2010.05.020
  19. SelvaDMLecubeAHernandezCBaenaJAFortJMSimoR. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin
  20. HiraiKHusseyHJBarberMDPriceSATisdaleMJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998; 58: 2359-2365
  21. TodorovPTMcDevittTMMeyerDJUeyamaHOhkuboITisdaleMJ. Purification and characterization of a tumor lipidmobilizing factor. Cancer Res. 1998; 58: 2353-2358
  22. PhilippAKralischSBachmannA. Serum levels of modialysis. Metabolism. 2011; 60: 669-672. doi: 10.1016/j.metabol.2010.06.01910.1016/j.metabol.2010.06.019 https://doi.org/10.1016/j.metabol.2010.06.019
  23. LealVOLoboJCStockler-PintoMB. Zinc-alpha2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients? Ren Fail. 2012; 34: 1062-1067. doi: 10.3109/0886022X.2012.712859 significance and prognostic implications. Nephrol Dial Transplant. role of adiponectin in chronic kidney disease. Biochimie. 2012; 94: and adipose tissue gene expression of zinc-alpha2-glycoprotein in Endocrinol Metab. 2009; 94: 4499-4507. doi: 10.1210/jc.2009-0758 the adipokine zinc-alpha2-glycoprotein are increased in chronic he-10.3109/0886022x.2012.712859 https://doi.org/10.3109/0886022x.2012.712859